Search results
Results from the WOW.Com Content Network
The development of heated humidified high flow started in 1999 with Vapotherm introducing the concept of high flow use with race horses. [2]High flow was approved by the U.S. Food and Drug Administration in the early 2000s and used as an alternative to positive airway pressure for treatment of apnea of prematurity in neonates. [3]
MDI canister and actuator components from H&T Presspart. A metered-dose inhaler consists of three major components: the canister, which is produced in aluminum or stainless steel by means of deep drawing, where the formulation resides; the metering valve, which allows a metered quantity of the formulation to be dispensed with each actuation; and an actuator (or mouthpiece) which enables the ...
Inhalant drugs are often used by children, teenagers, incarcerated or institutionalized people, and impoverished people, because these solvents and gases are ingredients in hundreds of legally available, inexpensive products, such as deodorant sprays, hair spray, contact cement and aerosol air fresheners. However, most users tend to be ...
“I imagine this is how physicians must have felt back in the day of polio,” said one doctor with Cook Children’s. Texas doctors finally have tools to prevent leading cause of hospitalization ...
U.S. health officials warned parents to avoid powdered infant formula sold by a Texas dairy producer, because a dangerous bacteria was found in one of the company's products. The Food and Drug ...
For premium support please call: 800-290-4726 more ways to reach us
The aerosol spray canister invented by USDA researchers, Lyle Goodhue and William Sullivan.. The concepts of aerosol probably go as far back as 1790. [1] The first aerosol spray can patent was granted in Oslo in 1927 to Erik Rotheim, a Norwegian chemical engineer, [1] [2] and a United States patent was granted for the invention in 1931. [3]
Infant respiratory distress syndrome (IRDS), also known as surfactant deficiency disorder (SDD), [2] and previously called hyaline membrane disease (HMD), is a syndrome in premature infants caused by developmental insufficiency of pulmonary surfactant production and structural immaturity in the lungs.